Lyra Therapeutics, Inc. financial data

Symbol
LYRA on Nasdaq
Location
480 Arsenal Way, Watertown, MA
Fiscal year end
December 31
Latest financial report
10-Q - Q2 2025 - Aug 12, 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 323 % -32.6%
Debt-to-equity 574 % +645%
Return On Equity -412 % -187%
Return On Assets -61.2 % +24.7%
Operating Margin -5.39K % +7.25%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 1.64M shares -97.5%
Common Stock, Shares, Outstanding 1.63M shares -97.5%
Common Stock, Value, Issued 2K USD -96.9%
Weighted Average Number of Shares Outstanding, Basic 1.35M shares +3.01%
Weighted Average Number of Shares Outstanding, Diluted 1.35M shares +3.01%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 770K USD -57.7%
Research and Development Expense 22.3M USD -60.4%
General and Administrative Expense 14.3M USD -29.6%
Operating Income (Loss) -41.5M USD +60.8%
Nonoperating Income (Expense) 2.7M USD -39.6%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest -38.8M USD +61.7%
Income Tax Expense (Benefit) 19K USD -67.8%
Net Income (Loss) Attributable to Parent -38.8M USD +61.7%
Earnings Per Share, Basic 30 USD/shares +85%
Earnings Per Share, Diluted 30 USD/shares +85%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 29.8M USD -6.65%
Assets, Current 31.1M USD -55.3%
Property, Plant and Equipment, Net 1.16M USD -30.4%
Operating Lease, Right-of-Use Asset 18.4M USD -14.6%
Assets 52.6M USD -44.4%
Accounts Payable, Current 680K USD -86.3%
Liabilities, Current 11.2M USD -42.1%
Operating Lease, Liability, Noncurrent 27.9M USD -14%
Liabilities 51M USD -19.9%
Retained Earnings (Accumulated Deficit) -421M USD -10.2%
Stockholders' Equity Attributable to Parent 1.62M USD -94.8%
Liabilities and Equity 52.6M USD -44.4%

Popular Metrics

Label TTM Value / Value Unit Change %
Common Stock, Shares Authorized 200M shares 0%
Common Stock, Shares, Issued 1.63M shares -97.5%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 31.8M USD -6.25%
Operating Lease, Liability 32.5M USD -11.6%
Depreciation 200K USD 0%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent -38.8M USD +61.7%
Lessee, Operating Lease, Liability, to be Paid 40M USD -13.9%
Property, Plant and Equipment, Gross 5.5M USD -4.25%
Operating Lease, Liability, Current 4.55M USD +6.63%
Lessee, Operating Lease, Liability, to be Paid, Year Two 5.13M USD -21%
Lessee, Operating Lease, Liability, to be Paid, Year One 6.49M USD +6.09%
Operating Lease, Weighted Average Discount Rate, Percent 0.06 pure 0%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 7.49M USD -22.7%
Lessee, Operating Lease, Liability, to be Paid, Year Three 4.51M USD -12.2%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10M shares 0%
Lessee, Operating Lease, Liability, to be Paid, Year Four 4.64M USD +3%
Preferred Stock, Shares Outstanding 0 shares
Share-based Payment Arrangement, Expense 5.17M USD -16.8%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%